20 COMMERCE DRIVE, SUITE 135, CRANFORD, NJ
Market cap: $4.8M (2/09/2026)
Price: $0.06
Seventh Amendment to Section 382 Rights Agreement Executed by Enzon Pharmaceu...
Enzon Pharmaceuticals Enters Sixth Amendment to Section 382 Rights Agreement
Announce Amendment to Merger Agreement
Securities Holder Rights or Indentures, News
Enter into Merger Agreement
News, Securities Holder Rights or Indentures
Material disclosure
Other Events
Q3
Q1
Amended Annual Report
FY 2023
Q2
FY 2023 amended
Effectiveness Notice
SC TO-I
Prospectus filed pursuant to Rule 424(b)(3)
S-4
Prospectus Filed Pursuant to Rule 425
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Amended Registration of Securities under Section 12(g)